Literature DB >> 27770372

microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.

Fei-Fei Wang1, Song Wang2, Wen-Hua Xue2, Jing-Liang Cheng3.   

Abstract

microRNAs (miRNAs), a family of small non-coding RNA molecules, are implicated in cancer growth and progression. In the present study, we examined the expression and biological roles of miR-590 in non-small cell lung cancer (NSCLC). Compared to normal lung tissues, miR-590 expression was downregulated in primary NSCLCs and, to a greater extent, in corresponding brain metastases. NSCLC cell lines with high metastatic potential had significantly (P < 0.05) lower levels of miR-590 than those with low metastatic potential. Re-expression of miR-590 suppressed NSCLC cell proliferation, colony formation, migration, and invasion in vitro and tumorigenesis in vivo. In contrast, inhibition of miR-590 enhanced the migration and invasion of NSCLC cells. Mechanistic studies revealed that a disintegrin and metalloproteinase 9 (ADAM9) was a direct target of miR-590. Delivery of miR-590 mimic was found to decrease endogenous ADAM9 expression in NSCLC cells. Enforced expression of a miRNA-resistant form of ADAM9 significantly restored the aggressive behaviors in miR-590-overexpressing NSCLC cells. Taken together, our data reveal miR-590 as a tumor suppressor in NSCLC, which is at least partially mediated through targeting of ADAM9. Restoration of miR-590 may provide a promising therapeutic strategy for NSCLC.

Entities:  

Keywords:  Cancer growth; Dysregulation; Metastasis; Target genes; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27770372     DOI: 10.1007/s11010-016-2822-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.

Authors:  Chen-Yuan Lin; Hung-Jen Chen; Cheng-Chung Huang; Liang-Chuan Lai; Tzu-Pin Lu; Guan-Chin Tseng; Ting-Ting Kuo; Qian-Yu Kuok; Jennifer L Hsu; Shian-Ying Sung; Mien-Chie Hung; Yuh-Pyng Sher
Journal:  Cancer Res       Date:  2014-07-24       Impact factor: 12.701

Review 2.  Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.

Authors:  Nam Bui; Brian Woodward; Anna Johnson; Hatim Husain
Journal:  Curr Treat Options Oncol       Date:  2016-05

3.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

4.  RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.

Authors:  Liang Chang; Fangchao Gong; Youbin Cui
Journal:  Mol Med Rep       Date:  2015-03-12       Impact factor: 2.952

Review 5.  Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment.

Authors:  Reinhard Buettner; Jürgen Wolf; Roman K Thomas
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 6.  microRNA and Lung Cancer.

Authors:  Valerio Del Vescovo; Michela A Denti
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-κB/MMP-9/VEGF pathways.

Authors:  Dongmei Li; Yucheng Wei; Dong Wang; Huijiang Gao; Kui Liu
Journal:  Biochem Biophys Res Commun       Date:  2016-01-28       Impact factor: 3.575

8.  ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.

Authors:  Masahide Ota; Satsuki Mochizuki; Masayuki Shimoda; Hitoshi Abe; Yuka Miyamae; Ken Ishii; Hiroshi Kimura; Yasunori Okada
Journal:  Cancer Sci       Date:  2016-03-16       Impact factor: 6.716

9.  MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer.

Authors:  Xiaoping Wu; Tianchi Liu; Ou Fang; Wenhua Dong; Fengjun Zhang; Lindsey Leach; Xiaohua Hu; Zewei Luo
Journal:  Oncotarget       Date:  2016-01-19

10.  MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1.

Authors:  Yao Dai; Zhigao Zhang; Yongxiang Cao; Jawahar L Mehta; Jun Li
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more
  10 in total

Review 1.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

Review 2.  Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.

Authors:  Sawsan Rashdan; Puneeth Iyengar; John D Minna; David E Gerber
Journal:  Transl Lung Cancer Res       Date:  2021-07

3.  MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.

Authors:  Lei Ding; Shanyong Zhang; Mu Xu; Renwen Zhang; Pengcheng Sui; Qing Yang
Journal:  J Exp Clin Cancer Res       Date:  2017-03-21

4.  MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6.

Authors:  Hongya Guan; Jia Liu; Pengju Lv; Lijuan Zhou; Jianying Zhang; Wei Cao
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

5.  MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.

Authors:  Dandan Li; Changjun He; Junfeng Wang; Yanbo Wang; Jianlong Bu; Xianglong Kong; Dawei Sun
Journal:  Oncol Res       Date:  2017-06-13       Impact factor: 5.574

6.  ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT.

Authors:  Chen-Yuan Lin; Chia-Fong Cho; Shih-Ting Bai; Jing-Pei Liu; Ting-Ting Kuo; Li-Ju Wang; Yu-Sen Lin; Ching-Chan Lin; Liang-Chuan Lai; Tzu-Pin Lu; Chih-Ying Hsieh; Chin-Nan Chu; Da-Chuan Cheng; Yuh-Pyng Sher
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

7.  MicroRNA-138 inhibits SOX12 expression and the proliferation, invasion and migration of ovarian cancer cells.

Authors:  Miaomiao Qu; Yongning Zhu; Meng Jin
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

8.  FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p.

Authors:  Jinglin Zhang; Yuhang Zhou; Tingting Huang; Feng Wu; Yi Pan; Yujuan Dong; Yan Wang; Aden K Y Chan; Liping Liu; Johnny S H Kwan; Alvin H K Cheung; Chi Chun Wong; Angela K F Lo; Alfred S L Cheng; Jun Yu; Kwok Wai Lo; Wei Kang; Ka Fai To
Journal:  Oncogene       Date:  2018-08-06       Impact factor: 9.867

9.  microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9.

Authors:  Weili Chen; Qing Lu; Siyu Li; Xinyue Zhang; Xiaohong Xue
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

Review 10.  An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.

Authors:  Cheng-Wei Chou; Yu-Kai Huang; Ting-Ting Kuo; Jing-Pei Liu; Yuh-Pyng Sher
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.